AMA Update

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Including the new “stealth Omicron” variant, as well as data from the latest CDC study showing third doses/booster shots bolster COVID defenses for both the immunocompromised and people with stronger immune systems. Also recapping AMA's joint statement with the American Hospital Association (AHA) and the American Nurses Association (ANA) on blood shortages.

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., about the important role physicians can play at this pivotal time in the pandemic and the support they need to do so.

AMA CXO Todd Unger talks with Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston, to learn about his new COVID vaccine and how it fits into our global pandemic response.

During #DataPrivacyWeek, AMA CXO Todd Unger talks with Laura Hoffman, JD, the AMA’s assistant director of federal affairs, about the importance of establishing guardrails for digital vaccination data and how physicians can address data privacy concerns with patients. Access the AMA's case for privacy by design in app development resource here: https://www.ama-assn.org/system/files/privacy-principles-by-design.pdf To learn more about AMA's health data privacy framework and advocacy work on the issue, visit: https://www.ama-assn.org/delivering-care/patient-support-advocacy/ama-health-data-privacy-framework

The webinar: "COVID-19: What to know about therapeutics and other treatment options" is scheduled for Tuesday, Feb. 1, at 3 p.m. Central time.Register and submit questions for the webinar here: https://www.ama-assn.org/delivering-care/public-health/covid-19-what-physicians-need-know-webinar-series

AMA CXO Todd Unger discusses clinician well-being in the COVID “new normal" with Jonathan Ripp, MD, MPH, dean for well-being and resilience at the Icahn School of Medicine at Mount Sinai and chief wellness officer at Mount Sinai Health System.

AMA CXO Todd Unger talks with Leana Wen, MD, MSc, public health professor at George Washington University, a columnist with the Washington Post, and a CNN medical analyst, about how physician communication and leadership can clear up COVID confusion for individual patients—as well as the nation.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering developments in COVID hot spots across the nation, the CDC's clarified stance on masks, and Dr. Fauci's "five phases of the pandemic."

AMA CXO Todd Unger talks with Leonard Nelson, JD, the AMA’s senior assistant general counsel, about the recent Supreme Court decisions on vaccine mandates and their long-term implications for physicians.

AMA CXO Todd Unger reviews rising COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also detailing what physicians and patients need to know about the CDC’s updated guidance on isolation, quarantine and testing.

AMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.

AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.

AMA CXO Todd Unger discusses the complex issue of vaccine mandates with three health system leaders: Robert Hart, MD, Chief Medical Officer, Ochsner Health; Adnan Munkarah, MD, Executive Vice President and Chief Clinical Officer, Henry Ford Health System; and Michael Anderson, MD, Chief Medical Officer, Virginia Mason Franciscan Health in this special COVID Update feature.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering an increase in COVID cases as the U.S. surpassed 50 million on Monday, new data from a major study released by South Africa’s largest health insurer on vaccine efficacy against Omicron, and an update on Pfizer's COVID pill.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of Omicron across the U.S. and globally, as well as New York City's vaccine mandate for private employees.

AMA CXO Todd Unger discusses the new omicron variant and what it means for the months ahead with good friend of the show, Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck's COVID pill.

AMA CXO Todd Unger talks with Paul Offit, MD, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, about pediatric COVID vaccination, mandates and boosters.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.

AMA CXO Todd Unger talks with Bechara Choucair, MD, vaccinations coordinator on the White House COVID-19 Response Team in Washington, D.C., about the nation’s vaccination strategy, including vaccine requirements, pediatric vaccination and boosters.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering legal challenges to the Biden administration's recent vaccine requirements for large companies and health workers, as well as ongoing efforts to vaccinate the nation's 5 to 11 year olds.

AMA CXO Todd Unger discusses what physicians need to know about the recent COVID vaccine authorization for children in the 5 to 11 age group with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA's authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA's support of the Biden Administration's plan to address the nation's overdose epidemic.

AMA CXO Todd Unger discusses Halloween and assessing risk heading into the holiday season with Dr. Aaron Carroll, a professor of pediatrics and chief health officer at Indiana University.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster news and current vaccine timeline for the 5 to 11 year old age group.

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

AMA CXO Todd Unger talks with the CDC's Dr. Alex Kallen, chief of the Prevention and Response Branch in the Division of Healthcare Quality Promotion, about the importance of infection prevention and control and what physicians need to know about updated guidance in this area.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients.

AMA CXO Todd Unger discusses navigating the resurgence of COVID cases in southern Florida with Dr. Bernie Fernandez, the CEO of Baptist Health Medical Group, and Bill Ulbricht the Chief Operating and Administrative Officer for the Clinical Enterprise division of Baptist Health South Florida.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA's J&J and Moderna booster EUA consideration, New York's vaccine mandate, and Merck's antiviral COVID-19 treatment pill.

AMA CXO Todd Unger talks with Dr. Pratima Sharma, executive medical director of primary care at EvergreenHealth, about how her health system quickly pivoted when it became the first location in the country to identify a COVID positive patient. Dr. Sharma shares strategies for ensuring physician well-being during crisis and how changes her health system made during the pandemic will influence care long term.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the booster roll out, mask studies in schools and the continued politicization of the pandemic.

AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic.

AMA CXO Todd Unger talks with AMA's Director of Science, Medicine and Public Health, Andrea Garcia, about trending topics related to the pandemic over the past week. Also covering Pfizer's announcement regarding vaccine effectiveness in 5-11 year olds, the FDA's decision on booster shots, and a state-by-state look at swings in COVID case count.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering recently released studies from the CDC, and what the data tells us about the effectiveness of COVID vaccines.

AMA CXO Todd Unger talks with Dr. Steven Stack, commissioner of the Kentucky Department of Public Health and former AMA president, about how Kentucky is faring in its battle with COVID, including the state's recent surge in cases and challenges posed by the politicization of health care issues.

A discussion with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA, about what physicians and patients really need to know about ivermectin.

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering booster shots, end-of-summer case numbers and trends, as well as the growing shortage of ICU beds across the U.S.

Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), a member of ACIP’s COVID-19 Vaccine Workgroup, and chair-elect of the AMA Board of Trustees, shares details from the latest ACIP meeting, including more details on the Pfizer approval, the latest vaccine safety data and the timeline for booster shots.

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering challenges faced by southern states in the wake of Hurricane Ida, and the U.S. returning to a daily average of more than 100,000 COVID-19 patients hospitalized.

A discussion with Dr. Paul Offit, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, about the importance of getting vaccinated and what physicians need to know about COVID and kids.

A discussion with LaShyra “Lash” Nolen, founding executive director of the We Got Us Empowerment Project and president of her medical school class at Harvard Medical School, about how she’s empowering Black communities to make decisions about COVID vaccines by providing accurate, culturally sensitive information in unique ways.

AMA president and family medicine specialist, Dr. Gerald Harmon, dives into the details about the FDA’s full approval of the Pfizer vaccine—and what it means for physicians and patients.

Discussion with AMA's Director of Science, Medicine and Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering the FDA's full approval of the Pfizer COVID-19 vaccine, booster shots and vaccine mandates.

A discussion with with Jordan Tralins, a rising junior at Cornell University and founder of the COVID Campus Coalition, about her work to address vaccine hesitancy among young adults. Follow COVID Campus Coalition on Instagram & TikTok @covid_campus_coalition or visit the website for more information: https://covidcampuscoalition.weebly.com/

Dr. Sandra Fryhofer, AMA’s liaison to ACIP and a member of ACIP’s COVID-19 Vaccine Workgroup, discusses what physicians need to know about the recent FDA authorization for a third COVID vaccine dose for immunocompromised patients.

Discussion with AMA's Director of Science, Medicine and Public Health, Andrea Garcia to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering third dose vaccines for the immunocompromised, vaccine recommendations for pregnant people, and state-level approaches for students headed back to school this fall.

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering global COVID-19 milestones, booster shots, and more detail on "younger, sicker, quicker" phrase/trend.

A discussion with Robin Gelburd, JD, president of FAIR Health in New York, about the organization’s recent study on patients with long-haul COVID in what is currently the largest study to date looking at long-term symptoms post-COVID infection.